Press Releases
-
Alfa Chemistry: Photochromic Materials Exhibit Intriguing Optical Properties
Earlier this month, Alfa Chemistry Materials announces the offering of photochromic materials, a material characterized by its optical properties being able to change reversibly upon irradiation. In fact, this company, reputed for the supply of all kinds of materials, has previously launched a wide array of other functional materials such as charge transfer complexes, macrocycles, phthalonitriles & naphthalonitriles, pressure & heat sensitive recording materials, semiconducting materials, silane coupling agents, and UV absorbents.
May 8, 2022
-
RHO HONORED AS SILVER STEVIE® AWARD WINNER IN 2022 AMERICAN BUSINESS AWARDS®
Rho, a global full-service contract research organization (CRO) with a proven track record of drug development success, was named the winner of a Silver Stevie® Award in the Fastest Growing Company of the Year category in the 20th Annual American Business Awards®.
May 8, 2022
-
Mdgroup launches new enterprise solution Primarius3 to integrate how sites, sponsors, healthcare practitioners and patients connect at every stage of the clinical trial journey
Mdgroup launches new enterprise solution Primarius3 to integrate how sites, sponsors, healthcare practitioners and patients connect at every stage of the clinical trial journey Bracknell, UK: 9 May 2022 – mdgroup, the leading global provider of healthcare technologies and personalised clinical study services, are transforming the clinical trial ecosystem with the launch of its enterprise solution Primarius3.
May 8, 2022
-
Ashfield Engage acquires ‘smart data’ organization PROPENSITY4
-
CD Formulation Provides Tailor-made Solutions for Thickener Excipients for Drug Development
-
Biopharma PEG Provides Large-Scale Monodispersed PEGs
Biopharma PEG is committed to supplying high quality polyethylene glycol (PEG) derivatives, PEG copolymers and PEG raw materials.
Apr 27, 2022
-
Adsorptive Polymers Are Now Available at Alfa Chemistry for Applications in Water Treatment, Medicine, Health Care, and Machine Processing
-
Alfa Chemistry Launches Heat Stabilizers for PVC Industry
-
Huateng Pharma Develops Caronic Anhydride for Paxlovid Intermediates
Paxlovid is the potencial blockbuster drugs for COVID-19 treatment. Huateng Pharma Develops Caronic Anhydride for Paxlovid Intermediates
Apr 27, 2022
-
Samsung Biologics Reports First Quarter 2022 Financial Results
-
World-first Scalp Cooling Summit unites industry leaders to discuss future of supportive cancer care
The first-of-its-kind Scalp Cooling Summit, where innovative global leaders in oncology and research will share their knowledge and understanding of precision side effect management, will take place digitally on May 5th, 2022.
Apr 26, 2022
-
CD ComputaBio Unveils Protein Structure Modeling Service for Drug Development
-
Untargeted Lipidomics Now Available with Creative Proteomics’s New Cutting-Edge Lipidomics Platform
-
Pronalyse Unveils Gene Therapy Products Characterization Service to Safely Accelerate Drug Development
-
Creative Proteomics Metabolomics Expands Service Offering with the Launch of Plant Untargeted Metabolomics Service
-
Biofourmis Receives Significant Growth Investment from General Atlantic to Propel Company to Unicorn Status
With this investment, Biofourmis plans to scale up its virtual care offerings. This includes delivering personalized and predictive in-home care to a growing number of acutely ill patients and expanding its recently announced virtual specialty care services, Biofourmis Care, to those patients with complex chronic conditions. In parallel, Biofourmis plans to fund clinical trials to advance the development of digital therapies that work in conjunction with high-value drugs to improve efficacy, while forming strategic partnerships with companies in the digital health and virtual-first care ecosystems.
Apr 25, 2022
-
Onyx Scientific opens second site and expands small molecule CMC services
-
WCG Selected as the Institutional Review Board of Record for The Michael J. Fox Foundation’s Parkinson’s Progression Markers Initiative
PPMI is designed to identify biological markers and clinical changes associated with Parkinson’s disease risk, onset, and progression.
Apr 25, 2022
-
MicrobioSeq Introduces Fungal Whole-Genome De Novo Sequencing Platform to Facilitate Microbial Research
-
CD Genomics Releases Human Mitochondrial DNA Sequencing for Disease Research and Biodiversity Assessment